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Cryptococcal meningitis (CM) is an infection of the brain parenchyma and subarachnoid space by the 
encapsulated saprophyte yeast organisms such as Cryptococcus neoformans. Over the last twenty years, 
HIV has created a large and severely immune compromisized population in whom C. neoformans is a 
dangerous opportunistic infection. In Guinea, the prevalence of CM is unknown. We hypothesized that the 




This retrospective observational study was carried out at the national Hospital of Conakry (Guinea) between 
2001 and 2002. We describe here the epidemiological and clinical and biological characteristics of CM 




Our data show that, 28.6 % of HIV patients with neurological symptoms had Cryptococcus neoformans in 
their CSF by using Indian ink staining. The median age was 36±3 years and sex ratio (M/F) was 1.8. The 
major complaints were fever and cephalgia, giddiness while the major complications were altered 
consciousness and hemiplegia. CSF was clear with low level of glucose and higher level of albumin. The 




This data therefore becomes relevant in not only focusing of neurological symptoms associated with HIV to 





be toxoplasmosis but the possibility of C neoformans in these patients; particularly when they present 








Cryptococcose méningée (CM) est une infection du parenchyme cérébral et de l’espace sous arachnoïdien 
par Cryptococcus neoformans. Durant les vingt dernières années, la CM a connue une flambée grâce à 
l`avènement du VIH/SIDA, et devenant ainsi, une des infections opportunistes dangereuse chez les 
immunodéprimés. En Guinée, sa fréquence n’est pas encore connue et elle pourrait être en corrélation avec 




Cette étude rétrospective a été effectuée à l’Hôpital National de Conakry, portant sur les patients admis 
entre 2001 et 2002. L’objectif était de décrire les caractéristiques épidémiologiques, cliniques et biologiques 




L’examen direct du liquide céphalorachidien à l’encre de Chine avait montré que, 28.6 % de patients 
infectés par le VIH admis avec des symptômes neurologiques, avait le C neoformans. L’âge médian était 
36±3 ans et le sex ratio (M/F) était 1.8. Les plaintes majeures étaient la fièvre et céphalées et vertiges 
tandis que les complications majeures étaient le trouble de la conscience (coma) et l’hémiplégie. La 
majorité des patients avaient le LCR clair avec une basse glycorhachie, une hyperalbuminorhachie et le 




A la lumière de ces résultats, il apparait utile de rechercher en plus de la toxoplasmose, la présence du C 
neoformans chez tout patient infecté par le VIH et particulièrement présentant des symptômes 
neurologiques comme céphalées, vertiges, raideur de la nuque etc. Cette recherche peut être réalisée par 






Cryptococcal meningitis (CM) is a common opportunistic infection in acquired immune deficiency syndrome 
（AIDS） patients, particularly in Southeast Asia and Africa[6,10,11,15]. It is AIDS defining illness in patients 
with late-stage Human Immunodeficiency Virus (HIV) infection, particularly in Southeast Asia and Southern 
and East Africa.[16,17,26]. Over the last 20 years, HIV infection pandemic has created a large and severely 
immune   compromized   population,   with   cryptococcal   meningitis   also   occurring   in   patients   with 
immunosupression. In parts of sub-Saharan Africa with the highest HIV prevalence, cryptococcal meningitis 
is now the leading cause of community-acquired meningitis, ahead of Streptococcus pneumoniae and 
Neisseria meningitidis[ 4,12,14,26]. Frequency of CM associated HIV infections varies from 2 to 35% 
according to the areas [9]. In the USA, about 7% [4,9]has been reported. In France, 88% of CM cases was 
associated with HIV infection [8,13]. While in Africa the range of frequency varies between 13 and 35% 
[5,8,11], 5.4% in Tunisia [18,19], 3,25% in Burkina Faso [21] and 5,4% in Ivory Coast [3]. In Uganda, the 
incidence of cryptococcal disease in patients with CD4 counts <200 cells/ml was estimated at 10.3 cases per 
100 person years of follow-up [9]. In Thailand, cryptococcosis accounted for 19% of AIDS-defining illnesses 
between 1994 and 1998[19]. It seems most likely the high incidence of cryptococcal meningitis in parts of 
Africa  and  Asia  reflects  differences  in  exposure  rather  than  host  susceptibility  or  cryptococcal  strain 
virulence, although no studies have addressed this issue [5,6,8,20]. Meningitis is the most frequent 
manifestation of cryptococcosis. Infection of the subarachnoid space is accompanied by involvement of the 
brain parenchyma, and therefore the term meningo-encephalitis may be more appropriate [11, 17,26]. 
 
Mortality from HIV associated cryptococcal meningitis remains high (10-30%), even in developed countries, 
because of the inadequacy of current antifungal drugs. In cohorts of HIV-infected patients from sub-Saharan 
Africa, cryptococcal meningitis has accounted for 13-44% of all deaths[26]. 
 
In Guinea, HIV prevalence increase from 1.7% in 1995, to 2.8% in 2002 [23] and the burden of CM is not yet 
clearly documented. We hypothesized that the frequency of CM associated HIV infection is correlated to HIV 
prevalence. In this study we describe the epidemiological characteristic, clinical presentation and CSF 
findings of CM in the national hospital of Conakry. 





MATERIALS AND METHODS 
 
This retrospective observational study was carried out at the national Hospital of Conakry (Guinea) between 
2001 and 2002. Seventy (70) HIV-infected patients were enrolled in the study. These patients underwent 
lumbar puncture as part of the routine work-up for a suspected neurological disease. The specimens of 
cerebrospinal fluid (CSF) from adult Human Immunodeficiency Virus-positive were taken for further 
mycological study. 
 
Cryptococcal meningitis was diagnosed based on one of the following: (i) a positive India ink CSF result only, 
(ii) a specific cryptococcal CSF antigen test, (iii) or a positive CSF culture for Cryptococcus neoformans, has 
not realized. 
 
Patients’ demographic data and clinical symptoms were collated from interviews of the patients. Physical 
findings, CSF examination (parameters such as glucose, albumin) outcome were analyzed. Informed 
consent was obtained from the patients enrolled in the study after ethical approval by the national ethics 
committee Statistical analysis: Statistical analysis was done using the statistical software ’EPI info version 
0.6’ (CDC Atlanta, USA). Descriptive analysis consisted of mean with standard deviation and range for 




Seventy (70) complete files from HIV patient hospitalized in Tropical and infectious diseases service of 
Donka national hospital, between 2001 and 2002 were recorded. Out of these seventy HIV patients, 28.6% 
had C. neoformans highlighted in their CSF after lumbar puncture using Indian ink staining (figure 1). 
Patients were categorized in age groups with a constant interval of 10. The majority of patients with CM 
associated HIV infection were in the group of 25-34 and 35-44 years of 40 and 45% respectively. Almost 
15% of patients were > 45 years (Table 1). The mean age was 36±3 years. The majority of patient was in the 
range from 25 and 44 years. Distribution of patients according to sex show that the majority were male 
(figure 2). 
 
According to their occupation, we found that one -third of the entire patients were drivers or apprentice 
drivers (30%), housewives and farmers (20%), workmen (20%), civil servants and others (15%) (Figure 3). 
 
Analysis of residence of the patients showed that majority were from the urban areas (townsmen) (75%) and 
25% from suburban areas (figure 4). The low number from suburban regions maybe due to their poor 
accessibility to the health care facility such as those in Donka National Hospital. However, information on 
other risk factors such as place of work, contact with pigeon, malnutrition, smoking, hepatitis C, etc were not 
collected. 
 
Clinical feature of Cryptococcal meningitis 
 
Cryptococcal meningitis presents a variety of symptoms and clinical signs; in this study we used the most 
frequent ones observed among all patients. The clinical presentation was almost the same of all the patients 
with few exceptions. Fever (100%), headache (56%) giddiness (65%), stiff neck (20%), tremor of the ends 
(20%), insomnia (50%), coma stage II (25%), Ptosis for both or one eyelid (20%) , deafness (20%) and 
hemiplegia by brain focal lesion (20%) (Table 2) are examples of the clinical presentations. 
 
Cerebrospinal Fluid (CSF) characteristics 
 
Visual observation of the collected CSF after the lumbar puncture was clear for most of the patients (95%) 
and in the other case the CSF was contaminated with blood. The red blood cells in the CSF was due to the 
procedural error during the lumbar puncture. 
 
The biochemical analysis showed that 56% of patients had a lower glucose average CSF of glucorrhchia 
and, glucorrhchia average was about 0.40±0.1 g/l. 
 
Our data showed that 75% of patients had higher protein average in CSF. The proteinorrhchia average was 
about (113±5 mg / dl). 
 
The lymphocyte count in CSF showed that 70% of patients had high number of lymphocytes, and the mean 




Cryptococcosis is a major opportunistic mycosis which has meningitis as its most frequent clinical 
presentation and can be fatal in the absence of antifungal therapy [1]. Cryptococcal meningitis is the most 
frequent nervous system disease after cerebral toxoplasmosis in HIV infection [15]. In this study the 
proportion of patients with CM using Indian ink staining was about 28.6% (Fig 1), which is consistent with the 
range observed in African countries between 10 to 35% [16]. The high frequency of CM in this study was due 
to the fact we included HIV patients with neurological symptoms. As a consequence of the increase in HIV- 
associated cryptococcosis, there has been a shift in the epidemiology of meningitis with cryptococcal 
meningitis now the leading cause of community-acquired meningitis, ahead of tuberculosis and bacterial 





meningitis which accounts for 20-45% of laboratory-confirmed cases in Southern Africa[ 15]. In Southeast 
Asia and Africa, cryptococcosis appears to be relatively more common as an AIDS-related infection than it 
ever was in Europe or North America [11]. In Burkina Faso, according to Millogo et al., real prevalence of this 
disease remains to be determined and could be still under estimated [21]. Mean age of the patients with CM 
associated HIV was 36±3 years. Our data showed that the highest frequencies were from ages 35 to 44 
(45%) and 25 to 34 years (40%), (Table I). This can be explained by the fact that these ranges of age were 
affected by HIV infection [23], which constitutes the main risk factor of CM because of their active sexual life 
[5;8;11;16 and17]. In Tunisia, Kalthoum et al., reported in their study that the mean age was about 33 years 
[18]. In Senegal, Sow et al., also reported an average of 37 years with the range between 21 to 56 years [2], 
while in France, Dromer F et al., [8] found an age group between 26 and 35 years old for HIV-positive 
patients and more than 46 years old for HIV-negative patients [8]. Most of the indian patients were in the age 
group 25-49 years and males dominated the study group [24]. In this study, the sex distribution showed that 
the male dominated in the group (13 men and 7 women) giving a sex ratio (M/F) of 1.8 (figure 2). The male 
domination has been reported in others studies [20;21]. This could imply that male are becoming more active 
sexually than their female counter parts. In this study, professional distribution of the CM patients showed 
that the drivers were more affected than other professions (figure 3). Previously it was shown that drivers, 
prostitutes, and soldiers were high risk professions for HIV infection and also at risk for CM. Our results 
confirm an early report according to HIV prevalence study in 2002 [23]. It appears the nature of their 
profession makes them have high contact with sexual prostitute. We, however, did not find the other 
occupations with high risk for HIV infection like the girls prostitutes. This study revealed, HIV infection was a 
risk factor for Cryptococcal Meningitis. We did not have information about other risk factors like the use of 
antitumor drugs, malnutrition, home and work place with pigeon or immunosuppressive treatment. 
 
Meningeal inflammation produced by Cryptococcus neoformans, an encapsulated yeast that tends to infect 
individuals with Acquired Immunodeficiency Syndrome (AIDS) and other immunocompromised states 
[6,10,11,15]. The organism enters the body through the respiratory tract, but symptomatic infections are 
usually limited to the lungs and nervous system [6,10,11,15]. Infection of the subarachnoid space is 
accompanied by involvement of the brain parenchyma, and therefore the term meningoencephalitis may be 
more appropriate [26]. Clinically, the course is sub-acute and may feature headache; nausea; photophobia; 
focal neurologic deficits; seizures; cranial neuropathies; and hydrocephalus [23]. In this study, all the patients 
manifested fever as complaint (20/20), headache (13/20) and giddiness (13/20) over several weeks. (Table 
2) Our results agree with the previously reported clinical features. In Senegal, Sow et al. [24], reported 
headache and vomiting among all patients and stiff neck among 4 patients out of 7 cases with coma. The 
major complication was hemiplegia [24]. Contrary to Anna’s results [1], Millogo et al. [21], reported that 
hemiplegia, stiff neck and sensory loss were not significant. 
 
Cryptococcal meningitis is a serious infection of the brain and spinal cord that can occur in people living with 
HIV. Many authors reported that the presence of CN in the brain and the CSF maybe responsible for the 
changes in CSF composition such as glucose, proteins and white cell number [6,10,11,15,17]. CSF protein 
was elevated for 75% of patients in this study; the protein average was about 1.13±0.5 g/l. Fifty-six percent 
(56%) had low mean CSF glucose of 0.40±0.1 g/L. In India, Susheel et al., reported low glucorrhachia of 
75% [25]. An increase of white blood cells indicates infection (include encephalitis), inflammation, or bleeding 
into the cerebrospinal fluid. Our data showed that 70% had higher lymphocyte count. Lymphocyte average 
was about 8±2cells /micro liter. 
 
Untreated cryptococcal meningitis is uniformly fatal, although survival can range from years in those without 
apparent immunocompromise to only a few weeks in HIV-associated infection [26]. In our study, the majority 
of patients were not receiving antifungical treatment and antiretroviral treatment, because they are very 
expensive for the majority of patients. Furthermore, drug acquisition costs are high for antifungal therapies 
as they are administered for 6-12 months. The Anti-retroviral Treatment (ART) was not accessible to 
everybody because it was not free at the time study was done. This low accessibility to ART and antifungical 
drugs was reported by many authors [3, 18,24). This study was relevant in that until now only a few case 
reports have been documented concerning the knowledge of this disease in Guinean patients. Thus to 
combat and minimize the scourge of the disease, ART need to be made accessible to the majority of 
patients. National hospitals and pharmacies should be supplied with them (ART) and the antifungical drugs 
too. 
 
In conclusion, this data therefore become relevant in not only focusing neurological symptoms associated 
with HIV to be due to toxoplasmosis but the possibility of C neoformans in these patients; particularly when 
they present symptoms such as headaches, giddiness and sniff neck etc. This can easily be carried out with 
Indian ink staining technique. 
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Figure 1: Frequency of CM associated HIV positive. This data represents 28.6% (20) of the seventy (70) 
HIV positive patients with neurological symptoms and positivity for C neoformans analysis in their 
cerebrospinal fluid (CSF). C neoformans analysis was done via Indian ink staining. 
 
Table 1: Distribution of patient according to age. 
 
Age group(years) Frequency % 
25-34 8 40 
35-44 9 45 
45-54 2 10 
55 -64 1 5 
Total 20 100 
 
This data represents 28.6% (20) of the seventy (70) HIV positive patients with neurological symptoms and 
positivity for C neoformans analysis in their cerebro spinal fluid (CSF). C neoformans analysis was done via 














Figure 2: Distribution of patient according to sex. Within the 28.6%(20) of the seventy (70) HIV positive 
patients that were positive for C. neoformans analysis in their cerebrospinal fluid (CSF). 





















Figure 3: Distribution of patient according to professions of the twenty (20) patients (out of the total 
seventy (70) HIV cases) who were positive for C. neoformans in their cerebrospinal fluid (CSF); C. 















Figure 4: Distribution of patient according to patient residence of the twenty (20) patients (out of the total 
seventy (70 HIV cases) who were positive for C. neoformans in their cerebrospinal fluid (CSF). 
 
Table 2: Distribution according to symptoms evoked and signs observed 
 
Symptoms and Signs Frequency/20* Percentage (%) 
Fever 20 100 
Céphalgia or headache 13 65 
Giddiness 13 65 
Insomnia 10 50 
Hypoesthesia 9 45 
coma stage II 5 25 
Stiff neck 4 20 
Tremors of the ends 4 20 
Amnesia 4 20 
Ptosis of eyelid 4 20 
Deafness 4 20 
Hemiplegia 1 5 
*Total of the twenty (20) patients  (out of the total seventy  (70) HIV cases)  who were positive for C. 
neoformans in their cerebrospinal fluid (CSF). Cryptococcal meningitis presents a variety of symptoms and 
clinical signs; we collected in this study the ones frequently evoked or observed among patients. Multiple 
signs were present in some patients 
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